Teipel R, Trautmann-Grill K, Kleditsch L, Epp K, Böttcher S, Röllig C, Weidner H, Gottschalk A, Glauche I, Brogsitter C, Platzek I, Apolle R, Bonin M von, Bornhäuser M, Winzer R, Miederer M. [18F]Fluorodeoxyglucose-PET/MRI-based response assessment following BCMA-directed CAR-T-cell therapy with ciltacabtagene autoleucel in relapsed/refractory multiple myeloma. haematol [Internet]. 2020Sep.10 [cited 2026May25];. Available from: https://haematologica.org/article/view/14189